Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
Professor Goldsteins research contributions include: Co-discovery and isolation of the thymosin family of peptides in the 1960s First clinical trials of thymosin preparations in immunodeficient children (1974) Characterization of thymosin beta-4s actin-binding and wound healing properties Development of therapeutic applications for tissue repair and regeneration Over 450 published scientific articles and 25+ patents related to thymosins Leadership in translating thymosin research toward clinical development Disclaimer: This spotlight is provided for educational purposes to acknowledge scientific contributions to BPC-157 and TB-500/thymosin beta-4 research
In Fitzpatrick III to VI patients, the breakout heals in weeks but the dark mark can last a year
Topical application takes slightly more effort but is still straightforward
Future research should prioritise long-term outcomes in high-risk groups, comparisons of physiological versus pharmacological dosages in healthy subjects, cost-effectiveness analyses, and adherence monitoring to inform clinical guidelines for the management and prevention of B12 deficiency
Yes, improving gut health is one of the most well-researched potential benefits of BPC-157
Chia CW, Odetunde JO, Kim W, Carlson OD, Ferrucci L, Egan JM (2014) GIP contributes to islet trihormonal abnormalities in type 2 diabetes
US$ 22.81
US$ 26.82
US$ 29.56
US$ 23.83
US$ 26.04
US$ 22.71
US$ 24.01
US$ 21.15
US$ 27.17